MILNER THERAPEUTICS SYMPOSIUM 2023


Wednesday 5th July
Cambridge, UK and Online

Milner Therapeutics Symposium 2023

Symposium Overview

The Milner Therapeutics Symposium 2023 took place on Wednesday 5th July. A fantastic line-up of speakers presented live at West Road Concert Hall in Cambridge, and talks were streamed to an online platform.

Our Annual Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and pre-clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. It is our key networking event for Milner Therapeutics Institute partner organisations.

If you have questions about the Symposium, please email symposium@milner.cam.ac.uk.

DOWNLOAD THE PROGRAMME » 

VIEW PHOTOGRAPHS FROM THE DAY » 

 

Information for Attendees

The Milner Therapeutics Symposium 2023 was a hybrid event. The in-person event was held at West Road Concert Hall in Cambridge, and sessions were also live-streamed to an online platform.

Speakers

Serena  Nik-Zainal (Early Cancer Institute, University of Cambridge), Wolf Reik (Altos Labs), Karen Duff (​UK Dementia Research Institute at University College London), Allan Bradley (Cambridge Institute of Therapeutic Immunology & Infectious Disease and T-Therapeutics), Cigall Kadoch (Dana-Farber Cancer Institute and Harvard Medical School) Mene Pangalos (AstraZeneca), Manav Pathania (Department of Oncology and Milner Therapeutics Institute), Debora Lucarelli (Enhanc3d Genomics) and David Walter and Douglas Ross-Thriepland (AstraZeneca Cancer Research Horizons Functional Genomics Centre).

Read more about our speakers further down this page.

Plenary Speakers

 

“Targeting the DNA damage response”

Serena Nik-Zainal

Early Cancer Institute
University of Cambridge

“Targeting the DNA damage response”

Wolf Reik

 Altos Labs

“Targeting the DNA damage response”

Karen Duff

UK Dementia Research Institute at University College London

“Targeting the DNA damage response”

Allan Bradley

Cambridge Institute of Therapeutic Immunology & Infectious Disease
and T-Therapeutics

 

“Targeting the DNA damage response”

Cigall Kadoch

Dana-Farber Cancer Institute
and Harvard Medical School

“Targeting the DNA damage response”

Mene Pangalos

 AstraZeneca

Spotlight Talks: Research and Entrepreneurship at the Milner Therapeutics Institute

“Targeting the DNA damage response”

Debora Lucarelli

Enhanc3d Genomics

“No Cancer Cell is an Island: why the microenvironment matters during pancreatic cancer progression and treatment”

Manav Pathania

Dept of Oncology and Milner Therapeutics Institute
University of Cambridge

Mo Zhao

Douglas Ross-Thriepland

Joint AstraZeneca-Cancer Research Horizons
Functional Genomics Centre

Mo Zhao

David Walter

Joint AstraZeneca-Cancer Research Horizons
Functional Genomics Centre

With thanks to our Symposium sponsors

Silver Sponsor:

Bronze Sponsors:

Pelago Bioscience Logo

MILNER THERAPEUTICS SYMPOSIUM

X